i m sally bundock with the top business stories. and we begin here in the uk where, as you ve been hearing, the nhs in england is braced for six days of strike action starting in an hour and a half, so 7am. and this marks the longest stretch of industrial action in the history of the national health service. junior doctors have been pushing for a 35% pay rise, which they say would restore their earnings after inflation to 2008 levels, but the government says this is unaffordable. for many decades, healthcare spending in western economies as a share of gdp has always risen, but recent research carried out by the economist claims that is no longer the case. so what is the cost of providing healthcare? an issue that will dominate in the run up to a general election here in the uk and a headache for most governments around the world. let s unpack this. i m joined by dr rocco friebel assistant professor of health policy at the london school of economics. good to have you on the
be assumed to be seeking care. ok. equally governments have been working very hard to address some of the supply side factors. there are various factors. there are various factors that have come into play to incentivise the use of generics rather than branded products, branded medicines, which come at a much lower price, and of course workforce. i keep dropping and i apologise. we have to leave it there because we re shopper time but thank you so much for giving us your insight into this from the london school of economics. this from the london school of economics- now let s bring you up to date on global trade. two of the world s biggest shipping firms have announced they ll continue to avoid sailing through the red sea, following further houthi rebel attacks on commercial vessels. maersk, which temporarily suspended the route on sunday after one of its ships was attacked, has now said it will avoid the red sea indefinitely. hapag lloyd says its vessels will use the much longer alter
Trustworthiness, standardisation of manufacturing processes and the composition of compounds are challenges that doctors say could interfere with treatment efficacy
Its large presence in India s branded generic drug market exposes it the most to a risk from trade generics. But other major pharma companies are at risk too
SRINAGAR: The SKIMS administration on Tuesday curtailed the visits of Medical Representatives to the hospital premises. The prescription of branded medicines has also been banned in the institute.